REGENXBIO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.19 USD | +0.81% |
|
+3.19% | -9.81% |
Chart calendar REGENXBIO Inc.
3dda8912f89d7045.77CDwO5hQWPVo4I3AlKUsU7zLVg5CuRi-9zqw9EbuuY.mcfzj9YbEg7t79JEVWLf0jSwbBZ3Wb5RopSghZZd0bmmwLTtrzk3EKDI1w~0d65910ac9cfc09f7a45d208a6f064b2
Upcoming events on REGENXBIO Inc.
Past events on REGENXBIO Inc.
| 03/04/2024 07:20 pm | Cantor Fitzgerald Virtual DMD and Other Dystrophy Day |
| 19/03/2024 01:00 am | UBS Virtual CNS Day |
| 14/03/2024 02:05 am | Barclays Global Healthcare Conference - Panel Discussion |
| 14/03/2024 01:35 am | Barclays Global Healthcare Conference |
| 12/03/2024 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 10:30 pm | Muscular Dystrophy Association Clinical & Scientific Conference |
| 05/03/2024 07:00 pm | AFFINITY DUCHENNE® Phase I/II Clinical Trial Results Call |
| 28/02/2024 03:00 am | Q4 2023 Earnings Call |
| 28/02/2024 02:35 am | Q4 2023 Earnings Release |
| 09/02/2024 04:30 am | World Symposium - Abstract Title Caregiver |
| 09/02/2024 04:30 am | World Symposium - Abstract Title Audiology |
| 08/02/2024 03:00 am | Rare Disease Program Update Call |
| 07/02/2024 10:06 pm | World Symposium |
| 06/02/2024 | Robert J. Gorlin Symposium |
| 17/01/2024 03:00 am | Hawaiian Eye and Retina Meeting |
| 17/01/2024 01:17 am | Hawaiian Eye and Retina Meeting |
| 29/11/2023 11:00 pm | Piper Sandler Healthcare Conference |
| 15/11/2023 01:30 am | Stifel Healthcare Conference |
| 09/11/2023 03:00 am | Q3 2023 Earnings Call |
| 09/11/2023 02:35 am | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 35,2 54,0 -34.71% | 155 219 -29.29% | 470 361 30.19% | 113 120 -6.42% | 90,2 108 -16.29% | 134 |
|
EBITDA Million USD | Released Forecast Spread | -142 -94,0 -50.9% | -111 -94,6 -17.17% | 170 184 -7.7% | -250 -279 10.29% | -251 -246 -1.77% | -120 |
|
EBIT Million USD | Released Forecast Spread | -149 -125 -18.86% | -119 -106 -12.75% | 160 -30,7 621.94% | -263 -265 0.65% | -268 -265 -1.34% | -234 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -97,5 -83,6 -16.66% | -106 -106 -0.35% | 141 -21,0 772% | -280 -266 -5.23% | -264 -259 -1.8% | -208 |
|
Net income Million USD | Released Forecast Spread | -94,7 -83,4 -13.58% | -111 -104 -6.78% | 128 46,7 173.58% | -280 -273 -2.82% | -263 -240 -9.65% | -211 |
|
EPS USD | Released Forecast Spread | -2,58 -2,27 -13.78% | -2,98 -2,91 -2.32% | 2,91 1,48 96.79% | -6,50 -6,29 -3.4% | -6,02 -5,27 -14.33% | -4,12 |
| Announcement Date | 26/02/20 | 01/03/21 | 01/03/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 399 296 34.8% | 22,2 29,2 -23.93% | 32,6 26,8 21.9% | 26,5 30,8 -13.96% | 31,3 37,5 -16.3% | 19,1 31,3 -38.84% | 20,0 34,5 -42.1% | 28,9 25,8 12.11% | 22,2 34,0 -34.69% | 23,5 | 25,2 | 26,8 | 42,7 | 21,4 |
|
EBITDA Million USD | Released Forecast Spread | 316 310 2% | -68,9 -58,1 -18.73% | -59,9 -64,7 7.48% | -67,5 -63,5 -6.23% | -53,6 -69,0 22.25% | -62,0 -73,9 16.15% | -68,7 -63,0 -9% | -60,6 -70,0 13.45% | ||||||
|
EBIT Million USD | Released Forecast Spread | 314 -55,0 670.24% | -71,5 -58,5 -22.28% | -62,5 -65,7 4.87% | -71,0 -65,3 -8.83% | -57,8 -71,5 19.21% | -66,2 -68,5 3.43% | -73,1 -63,0 -16.11% | -65,0 -69,3 6.28% | -63,9 -60,2 -6.08% | -60,4 | -60,0 | -59,1 | -57,3 | -55,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 307 139 121.13% | -76,8 -46,2 -66.33% | -68,2 -67,9 -0.43% | -75,5 -64,1 -17.77% | -60,0 -70,3 14.74% | -66,7 -58,2 -14.62% | -72,1 -52,4 -37.41% | -61,9 -67,6 8.53% | -63,0 -58,4 -7.9% | -58,6 | -57,7 | -55,4 | -36,5 | -51,3 |
|
Net income Million USD | Released Forecast Spread | 294 200 46.72% | -76,7 -50,2 -52.93% | -68,2 -67,7 -0.69% | -75,5 -64,7 -16.64% | -59,9 -65,2 8.13% | -66,7 -59,2 -12.6% | -72,1 -52,9 -36.17% | -61,9 -66,2 6.51% | -62,9 -57,4 -9.65% | -58,1 | -57,2 | -55,2 | -38,7 | -51,3 |
|
EPS USD | Released Forecast Spread | 6,67 4,68 42.54% | -1,79 -1,30 -38.05% | -1,58 -1,44 -9.8% | -1,75 -1,49 -17.72% | -1,38 -1,43 3.79% | -1,53 -1,39 -10.11% | -1,66 -1,23 -34.97% | -1,41 -1,48 4.58% | -1,43 -1,17 -22.71% | -1,27 | -1,24 | -1,18 | -0,86 | -1,12 |
| Announcement Date | 01/03/22 | 04/05/22 | 03/08/22 | 03/11/22 | 28/02/23 | 03/05/23 | 02/08/23 | 08/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for REGENXBIO Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RGNX Stock
- Calendar REGENXBIO Inc.
